Search PDMR transactions

Notifier
Name of person with notification obligation
David Augustsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
David Augustsson
Position
Other member of the company's administrative, management or supervisory body
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Oncopeptides BTA SE0027999608 Acquisition 1,070 Quantity 1.53 SEK 17/03/2026 NASDAQ STOCKHOLM AB
BTA Oncopeptides BTA SE0027999608 Acquisition 4,681 Quantity 1.53 SEK 17/03/2026 NASDAQ STOCKHOLM AB
BTA Oncopeptides BTA SE0027999608 Acquisition 6,756 Quantity 1.53 SEK 17/03/2026 NASDAQ STOCKHOLM AB
BTA Oncopeptides BTA SE0027999608 Acquisition 1,872 Quantity 1.53 SEK 17/03/2026 NASDAQ STOCKHOLM AB
BTA Oncopeptides BTA SE0027999608 Allotment 456 Quantity 1.55 SEK 16/03/2026 NASDAQ STOCKHOLM AB
BTA Oncopeptides BTA SE0027999608 Allotment 66 Quantity 1.55 SEK 16/03/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides BTA SE0027999608 Acquisition 17/03/2026 NASDAQ STOCKHOLM AB 14,379 (Quantity) 1.53 SEK
Oncopeptides BTA SE0027999608 Allotment 16/03/2026 NASDAQ STOCKHOLM AB 522 (Quantity) 1.55 SEK
<< Back